{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-097124","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.931080+00:00","generated_at":"2026-05-17T04:35:21.663107+00:00","sec_items":["9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Senseonics Q3 preliminary revenue $8.1M (+91% YoY); 1:20 reverse stock split effective Oct 17","bullets":["Preliminary unaudited revenue $8.1M for Q3 2025, up 91% vs Q3 2024.","US new patient starts grew ~160% YoY; September set record monthly starts.","1:20 reverse stock split reduces shares from ~816M to ~41M; effective 5:00 pm ET Oct 17, trading post-split Oct 20.","Sales and marketing organization brought in-house; DTC marketing driving awareness and patient growth.","Reverse split approved by stockholders Sep 29; Board set final ratio Oct 3."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-097124","json":"https://secwatch.observer/filing/0001104659-25-097124.json","markdown":"https://secwatch.observer/filing/0001104659-25-097124.md","text":"https://secwatch.observer/filing/0001104659-25-097124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465925097124/0001104659-25-097124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465925097124/tm2528088d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:35:21.663107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}